Home/Filings/4/0000879169-25-000085
4//SEC Filing

Stein Steven H 4

Accession 0000879169-25-000085

CIK 0000879169other

Filed

Jul 15, 8:00 PM ET

Accepted

Jul 16, 4:05 PM ET

Size

14.5 KB

Accession

0000879169-25-000085

Insider Transaction Report

Form 4
Period: 2025-07-14
Stein Steven H
EVP & Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2025-07-14$68.47/sh14,952$1,023,76397,466 total
  • Tax Payment

    Common Stock

    2025-07-14$69.98/sh1,555$108,81995,911 total
  • Tax Payment

    Common Stock

    2025-07-15$68.25/sh1,596$108,92794,315 total
  • Award

    Common Stock

    2025-07-15+12,277106,592 total
  • Award

    Performance Shares

    2025-07-15+30,69230,692 total
    Exp: 2028-07-15Common Stock (30,692 underlying)
  • Award

    Employee Stock Option (right to buy)

    2025-07-15+27,62927,629 total
    Exercise: $68.25Exp: 2035-07-14Common Stock (27,629 underlying)
Footnotes (5)
  • [F1]Represents shares withheld automatically by the Issuer to satisfy tax withholding obligations due at settlement of RSUs or earned performance shares previously reported in Table I as common stock.
  • [F2]Represents award of restricted stock units ("RSUs") that will vest 25% annually over four years. The RSUs may be settled only for shares of common stock on a one-for-one basis.
  • [F3]Including the July 15, 2025 grant, this includes an aggregate of 100,327 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested.
  • [F4]Each performance share represents the right to receive up to 200% of one share of common stock. Such shares may be earned based upon the issuer's relative total shareholder return ("TSR") over a three-year performance period beginning on January 1, 2025 as compared to the TSR of companies in a fixed peer group, as set forth in the Performance Share Award Agreement. The earned shares will vest on the third anniversary of the grant date subject to the Reporting Person's continued service with the issuer.
  • [F5]The July 15, 2025 options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.

Issuer

INCYTE CORP

CIK 0000879169

Entity typeother

Related Parties

1
  • filerCIK 0001673776

Filing Metadata

Form type
4
Filed
Jul 15, 8:00 PM ET
Accepted
Jul 16, 4:05 PM ET
Size
14.5 KB